Research programme: cancer vaccine CD55 - Scancell
Latest Information Update: 30 May 2007
At a glance
- Originator Scancell
- Developer Cancer Research Technology; Scancell
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 21 Jun 2004 Preclinical trials in Solid tumours in United Kingdom (unspecified route)